ABOUT US
We Are Trailblazing Clinical Trial Inclusivity & Experiences
Our Story
On a Monday morning, enough was enough, and although filled with disappointment a fire had ignited a change was imminent. I was told in my role that focusing on diversity in clinical trial recruitment was not good for business, however, this didn’t feel like it was about business, it felt personal to my core. I decided it was time to form a company that approached access to healthcare barriers from different lenses. So, I set out to create a solution that provides participant recruitment in real-time that is measurable, focuses on health equity and is powered by Real-World data.
Our mission is to bridge the disparity gap in clinical research by using health information to improve individual care, health economics, and healthcare outcomes for everyone. Simply put, we want a healthier world and are the middleman between science and everyday people at ACORN IQ we educate, support and build communities with people in the way they understand and trust”.
-Rosemary Lakeru
Founder, ACORN IQ
To Infinity And beyond
A mission with a purpose
We want to change the face of clinical research for diverse and under-representative populations using real-life data. pioneering a world where clinical research is not only inclusive of all people but also a world where we all have equitable health outcomes. Our mission is to bridge the disparity gap by using health information to improve health care, and health economics, educate, support and build communities with people in the way they like.
NOTHING EVER BECOMES REAL UNTIL IT IS EXPERIENCED
Experience can’t be learnt
We have been recruiting participants for clinical research studies globally in multiple therapeutic areas for over 10 years. Doing the same thing over and over again, and expecting a different result is insanity. That’s why we do not treat any project the same, our end-to-end solutions allow us to Identify, Understand, engage and recruit better-informed trial participants. We turn pre-Identified eligible people into enrolled participants, and we sprinkle our human touch on outreach & recruitment because we all value human interactions
Our Leadership Team
Meet The Incredibles
ROSEMARY LAKERU
FOUNDER & CEO
Rosemary Is an expert specialist in Patient Recruitment, Retention, Feasibility and Diversity & Inclusion services. Prior to ACORN IQ Rosemary worked with global pharmaceutical, Biotech, Patient Recruitment, CROs, and healthcare organisations in delivering world-class Patient Recruitment & Retention programmes and is a leader in delivering successful enrollment in multiple therapeutic clinical trials globally.
EDDY NGO
DATA SCIENTIST & PARTNER
Eddy is an experienced data scientist in analysing omics data, contributing cloud-based NGS analysis platforms,patient care use cases, and relational data models in several companies. Eddy builds machine learning models which will be used to improve healthcare outcomes for underrepresented populations in drug discovery.
JOIN OUR MISSION
Find out what we’re up to
To keep up to date with events, services and more, subscribe to our newsletter:
© Copyright 2023 ACORN IQ. All rights reserved
ABOUT US
We Are Trailblazing Clinical Trial Inclusivity & Experiences
Our Story
On a Monday morning, enough was enough, and although filled with disappointment a fire had ignited a change was imminent. I was told in my role that focusing on diversity in clinical trial recruitment was not good for business, however, this didn’t feel like it was about business, it felt personal to my core. I decided it was time to form a company that approached access to healthcare barriers from different lenses. So, I set out to create a solution that provides participant recruitment in real-time that is measurable, focuses on health equity and is powered by Real-World data.
Our mission is to bridge the disparity gap in clinical research by using health information to improve individual care, health economics, and healthcare outcomes for everyone. Simply put, we want a healthier world and are the middleman between science and everyday people at ACORN IQ we educate, support and build communities with people in the way they understand and trust”.
-Rosemary Lakeru
Founder, ACORN IQ
To Infinity And beyond
A mission with a purpose
We want to change the face of clinical research for diverse and under-representative populations using real-life data. pioneering a world where clinical research is not only inclusive of all people but also a world where we all have equitable health outcomes. Our mission is to bridge the disparity gap by using health information to improve health care, and health economics, educate, support and build communities with people in the way they like.
NOTHING EVER BECOMES REAL UNTIL IT IS EXPERIENCED
Experience can’t be learnt
We have been recruiting participants for clinical research studies globally in multiple therapeutic areas for over 10 years. Doing the same thing over and over again, and expecting a different result is insanity. That’s why we do not treat any project the same, our end-to-end solutions allow us to Identify, Understand, engage and recruit better-informed trial participants. We turn pre-Identified eligible people into enrolled participants, and we sprinkle our human touch on outreach & recruitment because we all value human interactions
Our Leadership Team
Meet The Incredibles
ROSEMARY LAKERU
FOUNDER & CEO
Rosemary Is an expert specialist in Patient Recruitment, Retention, Feasibility and Diversity & Inclusion services. Prior to ACORN IQ Rosemary worked with global pharmaceutical, Biotech, Patient Recruitment, CROs, and healthcare organisations in delivering world-class Patient Recruitment & Retention programmes and is a leader in delivering successful enrollment in multiple therapeutic clinical trials globally
EDDY NGO
DATA SCIENTIST & PARTNER
Eddy is an experienced data scientist in analyzing omics data, contributing cloud-based NGS analysis platforms, patient care use cases, and relational data models in several companies. Eddy builds machine learning models which will be used to improve healthcare outcomes for underrepresented populations in drug discovery.